Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.33 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL637380 | 0.96 | TSHR (0.43) | TSHRLMNATHRBALDH1A1TDP1 | |
| Water SCHEMBL5664000 | 0.96 | TSHR (0.43) | TSHRLMNATHRBALDH1A1TDP1 | |
| Bromide SCHEMBL636852 | 0.96 | TSHR (0.43) | TSHRLMNATHRBALDH1A1TDP1 | |
| Iodide SCHEMBL396287 | 0.96 | TSHR (0.43) | TSHRLMNATHRBALDH1A1TDP1 | |
| SCHEMBL12762111 | 0.96 | TSHR (0.43) | TSHRLMNATHRBALDH1A1TDP1 | |
| SCHEMBL3310909 | 0.93 | TSHR (0.40) | TSHRLMNATHRBALDH1A1TDP1 | |
| SCHEMBL4238292 | 0.93 | TSHR (0.47) | TSHRLMNATHRBALDH1A1SLC22A1 | |
| SCHEMBL3308158 | 0.93 | TSHR (0.40) | TSHRLMNATHRBALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL2466165 | 0.89 | TSHR (0.38) | TSHRLMNATHRBALDH1A1TDP1 | |
| SCHEMBL4235540 | 0.89 | TSHR (0.53) | TSHRLMNATHRBALDH1A1SLC22A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011992-A | UV-curing-delaying packaging adhesive for OLED display panel, OLED display panel and manufacturing method of OLED display panel | 惠州硕贝德半导体材料有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | nanoSUR LLC | 2025-04-10 | — | — | US | claimed |
| CN-108690217-B | Carbon fiber recycling composition and method | 波音公司 | 2022-07-15 | — | — | CN | claimed |
| EP-1825913-B1 | New catalyst systems and their application for metathesis reactions | LANXESS DEUTSCHLAND GMBH (DE) | 2016-08-17 | — | — | EP | claimed |
| WO-2015121357-A1 | METHOD FOR HYDROGENATING CARBON DIOXIDE INTO FORMAMIDES | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2015-08-20 | — | — | WO | claimed |
| WO-2015121476-A1 | METHOD FOR HYDROGENATING CARBON DIOXIDE INTO FORMATE | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2015-08-20 | — | — | WO | claimed |
| US-8530584-B2 | Process for reacting chemical compounds in the presence of catalyst systems | LANXESS DEUTSCHLAND GMBH (DE) | 2013-09-10 | — | — | US | claimed |
| US-20110077360-A1 | PROCESS FOR REACTING CHEMICAL COMPOUNDS IN THE PRESENCE OF CATALYST SYSTEMS | LANXESS DEUTSCHLAND GMBH (DE) | 2011-03-31 | — | — | US | claimed |
| EP-1151090-B1 | MULTIPLE ENZYME ASSAYS | APPLERA CORP (US) | 2009-09-02 | — | — | EP | claimed |
| US-20070208206-A1 | Novel catalyst systems and a process for reacting chemical compounds in the presence of said catalyst systems | LANXESS DEUTSCHLAND GMBH (DE) | 2007-09-06 | — | — | US | claimed |
| EP-1825913-A1 | New catalyst systems and their application for metathesis reactions | Lanxess Deutschland GmbH & Co.KG (DE) | 2007-08-29 | — | — | EP | claimed |
| US-6743484-B2 | CATALYST WHICH CATALYZES THE ADDITION REACTION OF THE ISOCYANATE-REACTIVE FUNCTIONAL GROUPS OF (B) WITH THE ACETYLENICALLY UNSATURATED TRIPLE BOND OF THE PROPARGYL GROUPS, AND THEIR USE AS COATING MATERIALS, ADHESIVES, AND | BASF COATINGS AG (DE) | 2004-06-01 | — | — | US | claimed |
| US-20030144383-A1 | Reactive mixtures of substances on the basis of propargyl-alcohol blocked polyisocyanates, method for preparing the same and the use thereof | BASF COATINGS AKTIENGESELLSCHAFT (DE) | 2003-07-31 | — | — | US | claimed |
| US-20020158225-A1 | Buffer compositions with volatile combustion products for use with gas-phase or vapor-phase element-specific detectors | VIGH GYULA (US) | 2002-10-31 | — | — | US | claimed |
| EP-1216989-A1 | Buffer compositions | THE TEXAS A & M UNIVERSITY SYSTEMS (US) | 2002-06-26 | — | — | EP | claimed |
| EP-0369076-B1 | Process for preparation of trisubstituted sulfonium and sulfoxonium salts of N-phosphonomethylglycine | ZENECA INC (US) | 1996-01-17 | — | — | EP | claimed |
| US-4225497-A | ACID CATALYSTS FOR IMIDATION | RHONE-POULENC INDUSTRIES (FR) | 1980-09-30 | — | — | US | claimed |
| US-12633573-B2 | Nonaqueous electrolyte energy storage device and method for manufacturing the same | GS YUASA INTERNATIONAL LTD. (JP) | 2026-05-19 | — | — | US | disclosed |
| US-4693742-A | Herbicidal hydroxyamino phosphonic acids and derivatives | ROHM AND HASS COMPANY (US) | 1987-09-15 | — | — | US | disclosed |
| US-4225497-A | ACID CATALYSTS FOR IMIDATION | RHONE-POULENC INDUSTRIES (FR) | 1980-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | NSUN2, NSUN3, RNGTT | TSHR 2929/4885LMNA 606/4885THRB 3747/4885 |
| US-20070208206-A1 | Novel catalyst systems and a process for reacting chemical compounds in the presence of said catalyst systems | NBAS, NNMT, CAT | TSHR 4549/4885LMNA 2515/4885THRB 4728/4885 |
| US-12633573-B2 | Nonaqueous electrolyte energy storage device and method for manufacturing the same | MCOLN2, CACNA2D2, TLL2 | TSHR 2452/4885LMNA 563/4885THRB 1842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.